← All organizations
Highest phase reached
Phase 2
First clinical trial
Nov 30, 2018Last known activity
Nov 30, 2018
Timeline
2000s
- Jun 1, 2009
Second Genome— Founded
Drugs by trial phase (1 distinct, 1 trials)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (2)
- NCT03676231Study directorPhase 2Nov 30, 2018
- NCT03676231Lead sponsorPhase 2Nov 30, 2018
Details
- Founded
- San Francisco, CA, US Jun 1, 2009
- Last known activity
- Nov 30, 2018